(Q36202581)

12 August 2017

1 reference

title

Inflammation, dyslipidaemia, diabetes and PPars: pharmacological interest of dual PPARalpha and PPARgamma agonists (English)

1 reference

12 August 2017

Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARα and PPARγ agonists (English)

0 references

1 reference

0 references

1 reference

B. Staels

3

0 references

author name string

Gervois P

1

1 reference

12 August 2017

Fruchart JC

2

1 reference

12 August 2017

Staels B

3

1 reference

12 August 2017

P. Gervois

1

0 references

J.-C. Fruchart

2

0 references

publication date

1 October 2004

1 reference

International journal of clinical practice. Supplement

12 August 2017

27 September 2004

0 references

published in

1 reference

International Journal of Clinical Practice

12 August 2017

0 references

volume

58

0 references

issue

143

1 reference

12 August 2017

page(s)

22-29

1 reference

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

PPARalpha activators inhibit tissue factor expression and activity in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-504X.2004.00376.X

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.1111/J.1368-504X.2004.00376.X

15 July 2023

Identifiers

DOI

0 references

1 reference